• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Bloom Energy Group Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket

    7/17/24 6:03:31 AM ET
    $ADVM
    $APVO
    $ASML
    $ASST
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ADVM alert in real time by email

    Shares of Bloom Energy Corporation (NYSE:BE) rose sharply in today's pre-market trading after the company announced a strategic partnership with CoreWeave.

    Bloom Energy said it entered into a partnership to deploy its proprietary fuel cells to generate on-site power for CoreWeave at a high-performance data center in Illinois.

    Bloom Energy shares jumped 12.1% to $16.90 in pre-market trading.

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Shimmick Corporation (NASDAQ:SHIM) gained 53% to $3.09 in pre-market trading after the company received a $27.6 million subcontract for the Sunol Valley Water Treatment Plant Ozonation Project.
    • Aptevo Therapeutics Inc. (NASDAQ:APVO) shares rose 39.3% to $0.46 in pre-market trading after surging around 10% on Tuesday. Aptevo Therapeutics recently announced closing of $2.75 million offering.
    • MicroAlgo Inc. (NASDAQ:MLGO) shares rose 26.1% to $3.58 in pre-market trading after declining around 14% on Tuesday.
    • Conduit Pharmaceuticals Inc. (NASDAQ:CDT) rose 16.1% to $0.2916 in pre-market trading. Conduit Pharmaceuticals shares gained around 5% on Tuesday after the company announced it received patent approval for its lead asset targeting autoimmune diseases..
    • Adverum Biotechnologies, Inc. (NASDAQ:ADVM) shares gained 15.5% to $10.31 in pre-market trading. Adverum Biotechnologies revealed 26-week interim analysis results of Ixo-vec from LUNA Phase 2 trial at 2024 ASRS Annual Meeting.
    • GitLab Inc. (NASDAQ:GTLB) gained 13.9% to $57.71 in pre-market trading after Reuters reported that the company is exploring a sale.
    • Asset Entities Inc. (NASDAQ:ASST) shares climbed 12.6% to $1.77 in pre-market trading.
    • Immersion Corporation (NASDAQ:IMMR) shares surged 12.4% to $13.69 in pre-market trading after gaining over 5% on Tuesday.
    • CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) shares gained 7.7% to $0.21 in pre-market trading.

    Losers

    • Cineverse Corp (NASDAQ:CNVS) shares fell 15.6% to $0.75 in pre-market trading.
    • Logistic Properties of the Americas (NYSE:LPA) shares fell 15.2% to $22.04 in pre-market trading after jumping 69% on Tuesday.
    • Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) shares fell 15.2% to $1.28 in pre-market trading after jumping 41% on Tuesday.
    • Five Below, Inc. (NASDAQ:FIVE) shares declined 14.7% to $87.00 in pre-market trading after the company announced a CEO transition. Additionally, comparable sales decreased in the 10-week period ended July 13.
    • Safe and Green Development Corporation (NASDAQ:SGD) shares dipped 11% to $0.3642 in pre-market trading.
    • Silo Pharma, Inc. (NASDAQ:SILO) shares fell 9.2% to $2.17 in pre-market trading. Silo Pharma shares jumped 123% on Tuesday after the company obtained an exclusive global license to develop, manufacture, and commercialize its Alzheimer’s drug.
    • Eightco Holdings Inc. (NASDAQ:OCTO) shares fell 8.7% to $0.48 in pre-market trading. Eightco Holdings recently said first-quarter revenue fell to $9.6 million from $15.9 million in the year-ago period.
    • Cerus Corporation (NASDAQ:CERS) fell 8.4% to $2.19 in pre-market trading. On July 2, Cerus announced the appointment of Dean Gregory to its Board of Directors.
    • Siebert Financial Corp. (NASDAQ:SIEB) fell 6.8% to $1.77 in pre-market trading after gaining over 9% on Tuesday.
    • ASML Holding N.V.  (NASDAQ:ASML) shares declined 6.8% to $995.90 in pre-market trading. ASML reported better-than-expected second-quarter earnings, driven by robust sales in China and a surge in new bookings.

    Now Read This:

    • Jim Cramer Says If You Sell This Chinese EV Stock Now, ‘Some Clown’ Will Be ‘Real Positive About It,’ Wait Until ‘All That Stuff Happens’
    Get the next $ADVM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADVM
    $APVO
    $ASML
    $ASST

    CompanyDatePrice TargetRatingAnalyst
    GitLab Inc.
    $GTLB
    12/17/2025$52.00Buy
    BTIG Research
    GitLab Inc.
    $GTLB
    12/16/2025Overweight → Sector Weight
    KeyBanc Capital Markets
    Five Below Inc.
    $FIVE
    12/8/2025$216.00Hold → Buy
    Truist
    Five Below Inc.
    $FIVE
    12/4/2025$170.00 → $195.00Outperform
    Telsey Advisory Group
    GitLab Inc.
    $GTLB
    12/3/2025$40.00Outperform → Neutral
    Macquarie
    Bloom Energy Corporation
    $BE
    12/2/2025Neutral
    Daiwa Securities
    GitLab Inc.
    $GTLB
    11/19/2025$44.00Buy → Hold
    Truist
    Adverum Biotechnologies Inc.
    $ADVM
    11/17/2025Buy → Neutral
    H.C. Wainwright
    More analyst ratings

    $ADVM
    $APVO
    $ASML
    $ASST
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CERo Therapeutics Provides Clinical Update on Phase 1 Clinical Trial of CER-1236 in AML (CertainT-1)

    Completion of DLT observation period for Cohort 1; first patient in Cohort 2 dosed at higher cell level; additional dosing in Cohort 1 SOUTH SAN FRANCISCO, Calif., Dec. 17, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (OTCQB:CERO) ("CERo" or the "Company"), an innovative cellular immunotherapy company pursuing new targets and novel phagocytic mechanisms, announces recent advances to the CertainT-1 trial that is focused on patients with acute myeloid leukemia (AML). Following completion of the dose-limiting toxicity (DLT) observation period for the first cohort, a total of 4e6 cells/kg of CER-1236 was delivered to the first patient of the second cohort. This patient received

    12/17/25 8:00:00 AM ET
    $CERO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Safe and Green Development Corporation Obtains 25% Pricing Increase on Recurring Compost Purchase Orders

    MIAMI, FL, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Safe and Green Development Corporation (NASDAQ:SGD) ("SGD" or the "Company") today announced that it has successfully implemented a 25% price increase on its recurring weekly compost purchase orders at its Myakka, Florida facility. The increase applies to compost sold to a consistent high-volume costumer, who accepted the revised pricing without any reduction in order volume. The pricing adjustment reflects strong underlying demand for the Company's compost products and demonstrates increasing pricing power across its materials processing platform. The increased pricing contributes directly to gross revenue and supports improved unit economics

    12/16/25 9:00:00 AM ET
    $SGD
    Real Estate
    Finance

    Shimmick Preferred Bidder on $81.5 Million in Water and Electrical Projects in Los Angeles Market

    IRVINE, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Shimmick Corporation (NASDAQ:SHIM) ("Shimmick" or the "Company"), a national leader in complex infrastructure solutions, has been named the preferred bidder on two projects in the Los Angeles market, totaling approximately $81.5 million in new work. The projects span water and electrical infrastructure and reflect growing demand for Shimmick's integrated civil and electrical delivery capabilities. "These projects reflect continued investment in essential water and electrical infrastructure that supports long-term resilience," said Ural Yal, Chief Executive Officer of Shimmick. "From advancing shore power to strengthening critical water rec

    12/16/25 8:30:00 AM ET
    $SHIM
    Military/Government/Technical
    Industrials

    $ADVM
    $APVO
    $ASML
    $ASST
    Leadership Updates

    Live Leadership Updates

    View All

    GitLab Appoints Jessica Ross As Chief Financial Officer

    All Remote, GitLab Inc. (NASDAQ:GTLB), the most comprehensive, intelligent DevSecOps platform, today announced the appointment of Jessica Ross as chief financial officer, effective January 15, 2026. Ross succeeds Interim CFO James Shen, who will return to his role as vice president of finance. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251202385769/en/Jessica Ross Ross' appointment comes as GitLab continues to see strong momentum, achieving 25% revenue growth in the third quarter of fiscal year 2026. She will oversee GitLab's global finance, accounting, and investor relations functions as the company accelerates DevSecOps inn

    12/2/25 4:06:00 PM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    Lilly to Acquire Adverum Biotechnologies

    Adverum's lead program, Ixo-vec, is a Phase 3 gene therapy designed to treat vision loss associated with wet age-related macular degeneration with a single intravitreal dose  Acquisition aligns Lilly's genetic medicine capabilities with opportunity to expand gene therapy's potential to alleviate the burden of age-related diseases  INDIANAPOLIS and REDWOOD CITY, Calif., Oct. 24, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) and Adverum Biotechnologies, Inc. (NASDAQ:ADVM), a clinical-stage company pioneering the use of intravitreal gene therapy with the aim of preserving sight for life in highly prevalent ocular diseases, today announced a definitive agreement for Lilly to acquire Adve

    10/24/25 8:30:00 AM ET
    $ADVM
    $LLY
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    ASML appoints next Chief Technology Officer

    ASML appoints next Chief Technology Officer Marco Pieters appointed ASML Chief Technology Officer ASML Supervisory Board intends to reappoint CFO Roger Dassen and COO Frédéric Schneider-Maunoury, and to appoint CTO Marco Pieters to the Board of Management as of the April 2026 AGM VELDHOVEN, The Netherlands, October 9, 2025 – ASML Holding NV (ASML) today announced the appointment of Marco Pieters as Executive Vice President and Chief Technology Officer, reporting to President and Chief Executive Officer, Christophe Fouquet. With over 25 years of experience at ASML, most recently as Executive Vice President for the product area Applications, Pieters has a strong track record in technology l

    10/9/25 2:00:00 AM ET
    $ASML
    Industrial Machinery/Components
    Technology

    $ADVM
    $APVO
    $ASML
    $ASST
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BTIG Research initiated coverage on GitLab with a new price target

    BTIG Research initiated coverage of GitLab with a rating of Buy and set a new price target of $52.00

    12/17/25 9:20:07 AM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    GitLab downgraded by KeyBanc Capital Markets

    KeyBanc Capital Markets downgraded GitLab from Overweight to Sector Weight

    12/16/25 8:41:52 AM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    Five Below upgraded by Truist with a new price target

    Truist upgraded Five Below from Hold to Buy and set a new price target of $216.00

    12/8/25 8:14:17 AM ET
    $FIVE
    Department/Specialty Retail Stores
    Consumer Discretionary

    $ADVM
    $APVO
    $ASML
    $ASST
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Weisblum Eric bought $2,075 worth of shares (5,000 units at $0.41), increasing direct ownership by 2% to 216,932 units (SEC Form 4)

    4 - Silo Pharma, Inc. (0001514183) (Issuer)

    12/16/25 6:34:59 PM ET
    $SILO
    Apparel
    Consumer Discretionary

    Chief Executive Officer Cole Matthew Ryan bought $415,999 worth of shares (515,195 units at $0.81), increasing direct ownership by 373% to 263,012 units (SEC Form 4)

    4 - Strive, Inc. (0001920406) (Issuer)

    12/16/25 9:04:18 AM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    CEO, PRESIDENT AND DIRECTOR Fischer Laurent bought $553,917 worth of shares (128,699 units at $4.30), increasing direct ownership by 177% to 201,513 units (SEC Form 4)

    4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)

    12/8/25 9:45:06 PM ET
    $ADVM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADVM
    $APVO
    $ASML
    $ASST
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13D/A filed by Strive Inc.

    SCHEDULE 13D/A - Strive, Inc. (0001920406) (Subject)

    12/17/25 8:59:52 PM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    SEC Form 425 filed by Strive Inc.

    425 - Strive, Inc. (0001920406) (Filed by)

    12/17/25 5:15:26 PM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    SEC Form 425 filed by Strive Inc.

    425 - Strive, Inc. (0001920406) (Filed by)

    12/17/25 5:11:54 PM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    $ADVM
    $APVO
    $ASML
    $ASST
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Barclay Kathleen S sold $400,466 worth of shares (2,200 units at $182.03), decreasing direct ownership by 19% to 9,214 units (SEC Form 4)

    4 - FIVE BELOW, INC (0001177609) (Issuer)

    12/17/25 6:43:01 PM ET
    $FIVE
    Department/Specialty Retail Stores
    Consumer Discretionary

    Chief Revenue Officer Steward Ian covered exercise/tax liability with 8,076 shares, decreasing direct ownership by 4% to 176,539 units (SEC Form 4)

    4 - Gitlab Inc. (0001653482) (Issuer)

    12/17/25 6:10:52 PM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    Interim CFO Shen James covered exercise/tax liability with 3,171 shares, decreasing direct ownership by 5% to 54,822 units (SEC Form 4)

    4 - Gitlab Inc. (0001653482) (Issuer)

    12/17/25 6:09:07 PM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    $ADVM
    $APVO
    $ASML
    $ASST
    Financials

    Live finance-specific insights

    View All

    Strive Increases SATA Perpetual Preferred Stock Dividend to 12.25%

    DALLAS, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Strive, Inc. (NASDAQ:ASST, SATA)) ("Strive" or the "Company") today announced an increase in the dividend rate on its Variable Rate Series A Perpetual Preferred Stock (the "SATA Stock"), raising the annual dividend rate to 12.25%, up from 12.00%. The increased dividend reflects Strive's continued commitment to enhancing shareholder value while maintaining disciplined management of its capital structure. The annual dividend rate is based on the $100 stated amount per share and is payable in monthly installments subject to declaration by Strive's board of directors. When declared, this corresponds to an annual dividend of approximately $12.25 per s

    12/15/25 8:30:00 AM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    Strive Announces $500,000,000 SATA At-The-Market Program

    DALLAS, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Strive, Inc. (NASDAQ:ASST, SATA)) ("Strive" or the "Company") today announced that it has entered into a sales agreement pursuant to which Strive may issue and sell shares of its Variable Rate Series A Perpetual Preferred Stock, $0.001 par value per share (the "SATA Stock"), having an aggregate offering price of up to $500,000,000 (the "ATM Program"). Strive intends to use the net proceeds from the ATM Program for general corporate purposes, including, among other things, the acquisition of bitcoin and bitcoin-related products and for working capital, the purchase of income generating assets to grow the Company's business, other capital expenditur

    12/9/25 6:27:45 PM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    Immersion Corporation Announces Significant Increase in Quarterly Dividend and Cooperation Agreement with Largest Shareholder

    Immersion Corporation ("Immersion," the "Company," "we," "us," or "our") (NASDAQ:IMMR), a leading provider of haptics technology, today announced that its Board of Directors (the "Board") has approved an increase in the quarterly dividend from $0.045 per share to $0.075 per share and has entered into a Cooperation Agreement with Scott A. Larson (the "Cooperation Agreement"). The quarterly cash dividend of $0.075 per share will be paid, subject to any prior revocation, in cash on January 30, 2026, to shareholders of record as of January 19, 2026. Eric Singer, Chairman and Chief Executive Officer, commented: "Since January 2023, we have distributed $0.78 per share in dividends to our shareh

    12/8/25 9:00:00 AM ET
    $IMMR
    Computer peripheral equipment
    Technology

    $ADVM
    $APVO
    $ASML
    $ASST
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by CERo Therapeutics Holdings Inc.

    SC 13G - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Subject)

    12/13/24 7:18:17 PM ET
    $CERO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by CERo Therapeutics Holdings Inc.

    SC 13G/A - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Subject)

    11/20/24 4:06:55 PM ET
    $CERO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G filed by CERo Therapeutics Holdings Inc.

    SC 13G - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Subject)

    11/20/24 4:01:41 PM ET
    $CERO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care